ReviewJournal of feline medicine and surgery2026
Feline comorbidities: cardiovascular and kidney diseases.
Review in Journal of feline medicine and surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Indoxyl Sulfate, Cardiac Biomarkers, and Left Ventricular Wall Thickening in Cats with Chronic Kidney Disease.Veterinary sciences · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
practical relevanceCardiovascular and kidney diseases are highly prevalent and frequently coexistent in cats, particularly those of advanced age. Several pathways of interaction between the heart and kidneys likely contribute to progressive functional decline of these systems during disease of one or both. Identification of heart or kidney disease in a cat should prompt the clinician to consider how the disease and its treatment might impact the function of the other organ and how coexisting primary disease of the other might impact case management and patient prognosis. CLINICAL CHALLENGES: A common goal in the management of congestive heart failure, acute kidney injury or chronic kidney disease is to maintain optimal body fluid balance; however, many therapies for disease of one system are at odds with the best interests of the other. For example, treatment of kidney disease often includes parenteral fluid therapy with the goal of maintaining mean arterial pressure and adequate renal blood flow, while diuretics are almost always necessary to reduce capillary hydrostatic pressure in cats with heart failure. Overly aggressive volume expansion or reduction during the management of kidney or heart failure, respectively, can lead to injury to or excessive stress on the other organ system. EVIDENCE BASE: Recommendations are based on available peer-reviewed literature and expert consensus guidelines when available. AUDIENCE: This article is aimed at all veterinary practitioners who work with cats.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.